Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the first quarter ended March 31, 2013, and provided an operating forecast and program updates.
“We have had an excellent start to 2013 and are excited about how quickly the company is evolving into a financial growth story,” said John Higgins, CEO and President of Ligand.
Help employers find you! Check out all the jobs and post your resume.
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the first quarter ended March 31, 2013, and provided an operating forecast and program updates.
“We have had an excellent start to 2013 and are excited about how quickly the company is evolving into a financial growth story,” said John Higgins, CEO and President of Ligand.
Help employers find you! Check out all the jobs and post your resume.
